Interleukin-6 promoter polymorphisms -174 G/C in Brazilian patients with systemic lupus erythematosus

Human Immunology

Volumn 74, Issue 9, 2013, Pages 1153-1156

  Asano, Nadja Maria ^a   Angelo, Hildson Dornelas ^a,b   da Silva, Helker Albuquerque ^a,c   Maia, Maria Mascena ^d   Lins, Otavio Gomes ^a   Souza, Paulo Eleutério ^d  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Science and Technology of Paraíba IFPB   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; ANXIETY DISORDER; ARTHRITIS; ARTICLE; BRAZIL; CLINICAL FEATURE; CONTROLLED STUDY; CONVULSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFLAMMATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOUTH ULCER; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROMOTER REGION; RASH; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; BRAZIL; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK; YOUNG ADULT;

EID: 84880939700     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.05.015     Document Type: Article

References (24)

1. La Cava A. Anticytokine therapies in systemic lupus erythematosus. Immunotherapy 2010, 2:575.
2. Ardoin S.P., Pisetsky D.S. Developments in the scientific understanding of lupus. Arthritis Res Ther 2008, 10:218.
3. Mina R., Brunner H.I. Pediatric lupus - are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?. Rheum Dis Clin North Am 2010, 36:53.
4. Illei G.G., Tackey E., Lapteva L., Lipsky P.E. Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. Arthritis Rheum 2004, 50:1709.
5. Illei G.G., Tackey E., Lapteva L., Lipsky P.E. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 2004, 5:2048.
6. Hay E.M., Bacon P.A., Gordon C., Isenberg D.A., Maddison P., Snaith M.L., et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993, 86:447.
7. Chen W.F., Fischer M., Frank G., Zlotnik A. Distinct patterns of lymphokine requirement for the proliferation of various subpopulations of activated thymocytes in a single cell assay. J Immunol 1989, 143:1598.
8. May L.T., Santhanam U., Tatter S.B., Bhardwaj N., Ghrayeb J., Sehgal P.B. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. Biochem Biophys Res Commun 1988, 152:1144.
9. Godarzi E.M., Sarvestani E.K., Aflaki E., Amirghofran Z. Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus. Clin Rheumatol 2011, 30:179.
10. Huang C.M., Huo A.P., Tsai C.H., Chen C.L., Tsai F.J. Lack of association of interleukin-6 and interleukin-8 gene polymorphisms in Chinese patients with systemic lupus erythematosus. J Clin Lab Anal 2006, 20:255.
11. Santos M.J., Fernandes D., Capela S., da Silva J.C., Fonseca J.E. Interleukin-6 promoter polymorphism -174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients. Clin Rheumatol 2011, 30:409.
12. Abbas D., Hamdy E., Helal M.M. Promoter region polymorphism (-174 G/C) of interleukin-6 gene and SLE; are they associated?. Egypt Rheumatol 2011, 33:69.
13. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369.
14. Hulkkonen J., Pertovaara M., Antonen J., Pasternack A., Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 2001, 40:656.
15. Papassotiropoulos A., Hock C., Nitsch R.M. Genetics of interleukin 6: implications for Alzheimer's disease. Neurobiol Aging 2001, 22:863.
16. Libra M., Signorelli S.S., Bevelacqua Y., Navolanic P.M., Bevelacqua V., Polesel J., et al. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. J Clin Pathol 2006, 59:211.
17. Georges J.L., Loukaci V., Poirier O., Evans A., Luc G., Arveiler D., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med (Berl) 2001, 79-300.
18. Chua K.H., Kee B.P., Tan S.Y., Lian L.H. Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus. Braz J Med Biol Res 2009, 42:551.
19. Hamdy E., Afify R.A.A., Kamal A., Abass D., Mahmoud M. IL-6 promoter polymorphism (-174G/C) and systemic lupus erythematosus. Comp Clin Pathol 2011, 1:1.
20. Unfried G., Böcskör S., Endler G., Nagele F., Huber J.C., Tempfer C.B. A polymorphism of the interleukin-6 gene promoter and idiopathic recurrent miscarriage. Hum Reprod 2003, 18:267.
21. Linker-Israeli M., Deans R.J., Wallace D.J., Prehn J., Ozeri-Chen T., Klinenberg J.R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991, 147:117.
22. Schotte H., Schlüter B., Rust S., Assmann G., Domschke W., Gaubitz M. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001, 40:393.
23. Belluco C., Olivieri F., Bonafè M., Giovagnetti S., Mammano E., Scalerta R., et al. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res 2003, 9:2173.
24. Panoulas V., Stavropoulos-Kalinoglou A., Metsios G., Smith P., Milionis H., Karen M.J. Association of interleukin-6 (IL-6) -174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis 2009, 204(1):178.